A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT)
NCT02312258
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
706
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Placebo
DRUG:
Ixazomib
Sponsor
Takeda